![Yaysie Figueroa](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Yaysie Figueroa worked as a Director of Clinical Program Management at Vertex Pharmaceuticals, Inc. and as an Executive Director of Clinical Operations at Bioverativ, Inc. She also briefly worked as an Executive Director of Clinical Operations at Imara, Inc. Ms. Figueroa received an undergraduate degree from Colgate University.
| Bedrijven | Functie | Einde |
|---|---|---|
| VERTEX PHARMACEUTICALS INCORPORATED | Hoofd Techniek/Wetenschap/O&O | - |
| BIOVERATIV INC | Corporate Officer/Principal | - |
| IMARA | Hoofd Techniek/Wetenschap/O&O | - |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
| Bedrijven in privébezit | 4 |
|---|---|
Vertex Pharmaceuticals, Inc.
 Vertex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops drugs for the treatment of cystic fibrosis | Health Technology |
Colgate University
 Colgate University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Imara, Inc.
 Imara, Inc. Pharmaceuticals: MajorHealth Technology Develops and distributes novel therapeutics for patients with sickle cell disease | Health Technology |
Bioverativ, Inc.
 Bioverativ, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that engages in discovery, research, development and commercialization of therapies for hemophilia & blood disorders | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau
